反応 #71732

ord-02a832113aa14273a16e5cd68c540475

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    抽出followed by extraction with dichloromethane
  2. 2
    洗浄The organic layer was washed with brine
  3. 3
    乾燥dried over anhydrous sodium sulfate
  4. 4
    濃縮concentration under reduced pressure
  5. 5
    その他the residue was purified by silica gel column chromatography (elution solvent: hexane/ethyl acetate=4/1, 3/1, 1/1)

実験手順

Ethyl cis(±)-2-(4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-methoxypiperidin-1-yl)-4-(hydroxymethyl)-1,3-thiazole-5-carboxylate obtained by the method described in Example (27b) (0.14 g, 0.30 mmol) was dissolved in dichloromethane (5 mL). A solution of DAST (0.05 mL, 0.38 mmol) in dichloromethane (2 mL) was added dropwise at −40° C. The mixture was stirred at that temperature for 30 minutes. Brine was added to the reaction solution, followed by extraction with dichloromethane. The organic layer was washed with brine and dried over anhydrous sodium sulfate. Following concentration under reduced pressure, the residue was purified by silica gel column chromatography (elution solvent: hexane/ethyl acetate=4/1, 3/1, 1/1) to obtain 83 mg of the title compound as a colorless oily substance (59%).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US08536197B2uspto-grants-2013_09